We further show that SLFN11 mRNA level is a tumor biomarker predictive of overall survival (OS) and enhanced tumor response in breast, lung, and ovarian cancer patients treated with these chemotherapeutics. The gene discussed is SLFN11; the disease is ovarian cancer.